Showing results (181-190 of 291) with videos related to

Sort By:
Pageof 30
International Journal of Radiation Oncology, Biology, Physics|September 19, 2015
Mapping Patterns of Ipsilateral Supraclavicular Nodal Metastases in Breast Cancer: Rethinking the Clinical Target Volume for High-risk PatientsHao Jing, Shu-Lian Wang, Jing Li, et al.
BMC Cancer|March 11, 2017
Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rateYan-Ru Feng, Jing Jin, Hua Ren, et al.
Chinese Medical Journal|August 19, 2020
Oral contrast agents lead to underestimation of dose calculation in volumetric-modulated arc therapy planning for pelvic irradiationHao Jing, Yuan Tian, Yu Tang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 29, 2023
Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: A multicenter retrospective studyYu-Chun Song, Jie Kong, Na Li, et al.
Nature Communications|December 4, 2019
Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticlesXiaodong Xie, Huifang Nie, Yu Zhou, et al.
Plos One|July 19, 2014
A nation-wide multicenter 10-year (1999-2008) retrospective clinical study of endocrine therapy for Chinese females with breast cancerCan Zhou, Jian jun He, Jing Li, et al.
Blood|October 9, 2009
Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescentsZhao-Yang Wang, Ye-Xiong Li, Wei-Hu Wang, et al.
Nature Communications|January 9, 2020
Publisher Correction: Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticlesXiaodong Xie, Huifang Nie, Yu Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphomaYe-Xiong Li, Qing-Feng Liu, Hui Fang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 22, 2022
First-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Randomized Phase 2 Study in ChinaYue Chai, Bo Chen, Fei Qi, et al.
Pageof 30